Efficacy and safety of peginterferon ?-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples